JP2023551110A5 - - Google Patents

Info

Publication number
JP2023551110A5
JP2023551110A5 JP2023527430A JP2023527430A JP2023551110A5 JP 2023551110 A5 JP2023551110 A5 JP 2023551110A5 JP 2023527430 A JP2023527430 A JP 2023527430A JP 2023527430 A JP2023527430 A JP 2023527430A JP 2023551110 A5 JP2023551110 A5 JP 2023551110A5
Authority
JP
Japan
Prior art keywords
ethyl
fluorobicyclo
dicyclopropyl
pentan
imidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023527430A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023551110A (ja
Filing date
Publication date
Priority claimed from GBGB2017642.6A external-priority patent/GB202017642D0/en
Priority claimed from GBGB2108945.3A external-priority patent/GB202108945D0/en
Application filed filed Critical
Priority claimed from PCT/EP2021/080251 external-priority patent/WO2022096412A1/en
Publication of JP2023551110A publication Critical patent/JP2023551110A/ja
Publication of JP2023551110A5 publication Critical patent/JP2023551110A5/ja
Pending legal-status Critical Current

Links

JP2023527430A 2020-11-09 2021-11-01 Ｉｌ‐１７モジュレーターとしてのジシクロプロピルメチル誘導体 Pending JP2023551110A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB2017642.6A GB202017642D0 (en) 2020-11-09 2020-11-09 Therapeputic agents
GB2017642.6 2020-11-09
GB2108945.3 2021-06-22
GBGB2108945.3A GB202108945D0 (en) 2021-06-22 2021-06-22 Therapeutic agents
PCT/EP2021/080251 WO2022096412A1 (en) 2020-11-09 2021-11-01 Dicyclopropylmethyl derivatives as il-17 modulators

Publications (2)

Publication Number Publication Date
JP2023551110A JP2023551110A (ja) 2023-12-07
JP2023551110A5 true JP2023551110A5 (https=) 2024-10-15

Family

ID=78536191

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023527430A Pending JP2023551110A (ja) 2020-11-09 2021-11-01 Ｉｌ‐１７モジュレーターとしてのジシクロプロピルメチル誘導体

Country Status (6)

Country Link
US (1) US20230399328A1 (https=)
EP (1) EP4240742A1 (https=)
JP (1) JP2023551110A (https=)
CN (1) CN116406267A (https=)
CA (1) CA3199816A1 (https=)
WO (1) WO2022096412A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR126255A1 (es) 2021-07-01 2023-10-04 UCB Biopharma SRL Derivados de imidazotriazina como moduladores de il-17
WO2023025783A1 (en) 2021-08-23 2023-03-02 Leo Pharma A/S Small molecule modulators of il-17
WO2023111181A1 (en) 2021-12-16 2023-06-22 Leo Pharma A/S Small molecule modulators of il-17
WO2023166172A1 (en) 2022-03-04 2023-09-07 Leo Pharma A/S Small molecule modulators of il-17
GB202210731D0 (en) 2022-07-22 2022-09-07 UCB Biopharma SRL Therapeutic agents
TW202430165A (zh) 2022-12-02 2024-08-01 丹麥商理奧藥品公司 Il-17之小分子調節劑

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2242504B1 (en) 2008-01-09 2021-07-14 The Schepens Eye Research Institute, Inc. Therapeutic compositions for treatment of ocular inflammatory disorders
EP2809660B1 (en) 2012-02-02 2016-01-20 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating il-17
WO2014066726A2 (en) 2012-10-26 2014-05-01 Ensemble Therapeutics Corporation Compounds for modulating il-17
GB201709456D0 (en) 2017-06-14 2017-07-26 Ucb Biopharma Sprl Therapeutic agents
US11472794B2 (en) * 2018-01-15 2022-10-18 UCB Biopharma SRL Fused imidazole derivatives as IL-17 modulators
CN110511213B (zh) 2018-05-22 2021-10-19 成都先导药物开发股份有限公司 一种免疫调节剂
EP3820567A1 (en) 2018-07-12 2021-05-19 UCB Biopharma SRL Spirocyclic indane analogues as il-17 modulators
GB201820165D0 (en) 2018-12-11 2019-01-23 Ucb Biopharma Sprl Therapeutic agents
GB201820166D0 (en) 2018-12-11 2019-01-23 Ucb Biopharma Sprl Therapeutic agents
SG11202106444WA (en) * 2018-12-19 2021-07-29 Leo Pharma As Amino-acid anilides as small molecule modulators of il-17
TWI752400B (zh) 2019-01-07 2022-01-11 美商美國禮來大藥廠 Il-17a抑制劑
US20220162191A1 (en) 2019-03-08 2022-05-26 Leo Pharma A/S Small molecule modulators of il-17
GB201909191D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
GB201909190D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
GB201909194D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents

Similar Documents

Publication Publication Date Title
JP2023551110A5 (https=)
ES2654847T3 (es) Compuestos de benzoxazol y benzotiazol sustituidos en 6-O y métodos para inhibir la señalización CSF-1R
JP2020506946A5 (https=)
HRP20220177T1 (hr) Heteroaril supstituirani beta-hidroksietilamini za upotrebu u liječenju hiperglikemije
JP2015514679A5 (https=)
AU2012292036C1 (en) Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
JP2016523911A5 (https=)
JP2024518792A5 (https=)
JP2018522823A5 (https=)
RU2016133626A (ru) 2-амино-3,5,5-трифтор-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1 для лечения болезни альцгеймера
RU2011116226A (ru) Пиразолопиридиновые производные как ингибиторы надфн-оксидазы
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
RU2017116197A (ru) 2-амино-3,5-дифтор-3,6-диметил-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 для лечения болезни альцгеймера
RU2012126989A (ru) 2-амино-5,5-дифтор-5,6-дигидро-4н-оксазины в качестве ингибиторов васе 1 и(или) васе 2
CA2670605A1 (en) Substituted arylpyrazoles
RU2018104868A (ru) 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1
HRP20100121T1 (hr) Derivati n-(aminoheteroaril)-1h-indol-2-karboksamida, njihovo dobivanje i terapijska primjena
JP2022511209A5 (https=)
IL276998B1 (en) Piperidinyl-3-(aryloxy)propanamides and propanoates
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
RU2008108219A (ru) Соединения, представляющие собой 5-(фенилизоксазолилэтокси)-триазол-3-ил-замещенный пиридин, для лечения неврологических, психиатрических или болевыхрасстройств
CN102686572A (zh) 用于治疗cns病的噁唑啉衍生物
CN103596937A (zh) 取代的苯甲酰胺衍生物
JP2013513615A (ja) 脂肪酸アミドヒドロラーゼのアゾ環状阻害薬
RU2014132044A (ru) Гетероциклические производные в качестве рецепторов, ассоциированных со следовыми аминами (taars)